Europe Startup Funding Rounds
Startups raising capital across Europe. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 1,479 Jan 1 – Oct 24, 2026
- Disclosed funding
- $63.4B 1202 disclosed amounts
- Median round
- $6.9M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| V VARMCompany profile Trains career changers to become certified insulation installers and deploys them across Europe Trains career changers to become certified insulation installers and deploys them across Europe | €17.5M | Series A | Climate tech | Germany | Investors | |
| UT Ubotica TechnologiesCompany profile Provides real-time maritime intelligence from space using AI-powered analysis Provides real-time maritime intelligence from space using AI-powered analysis | $11M | Undisclosed | Space tech | Ireland | Investors | |
| AS Astral SystemsCompany profile Develops multi-state fusion technology for medical radioisotopes and commercial applications Develops multi-state fusion technology for medical radioisotopes and commercial applications | £23M | Series A | Industrial tech | United Kingdom | Investors | |
| K KyrokCompany profile Builds an AI operating system for supply chain management in pharma and chemical SMEs across Europe Builds an AI operating system for supply chain management in pharma and chemical SMEs across Europe | €3.1M | Pre-SeedPre-seed | Biotech | Germany | Investors | |
 AcodyneCompany profile Autonomous cargo aircraft combining vertical take-off with fixed-wing flight for heavy-lift logistics. Autonomous cargo aircraft combining vertical take-off with fixed-wing flight for heavy-lift logistics. | €2.5M | Pre-SeedPre-seed | Defense tech | Denmark | Investors | |
 Bionyra PharmaCompany profile Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases. Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases. | $165M | Series A | Biotech | France | Investors | |
| LT Lys TherapeuticsCompany profile Develops monoclonal antibody LYS241 targeting neurovascular pathways for Parkinson's disease and stroke Develops monoclonal antibody LYS241 targeting neurovascular pathways for Parkinson's disease and stroke | >€25M | Seed | Biotech | France | Investors | |
| S Provides AI coworker platform built inside Slack for task automation | €500K | Pre-SeedPre-seed | AI | Lithuania | Investors | |
| S Manufactures commercial electric vehicles for middle mile logistics | $21M | Series A | Mobility | United Kingdom | Investors | |
| G Provides shared infrastructure for last-mile parcel delivery | €4M | Seed | Ecommerce | Czech Republic | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1High-Tech Gründerfonds
Rabot Energy, TODAY, Finches
39rounds4led - 2Antler
Jenz, Affinity Labs, CodeWall
26rounds0led - 3Y Combinator (YC)
HyLight, Sensible Biotechnologies, Revnu
22rounds1led - 4General Catalyst
Legora, Complir, Integral
21rounds1led - 5Index Ventures
Opply, Duvo, Spiko
21rounds2led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.